David Piccioni
Neurology · Los Angeles, CANPI 1851542575
Payments from drug & device makers
Across 305 payments — averaging $9410.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Servier Bioinnovation$1.6M
- E.r. Squibb & Sons, L.L.C.$640K
- Novocure GmbH$242K
- Servier Pharmaceuticals LLC$95K
- Agios Pharmaceuticals, Inc.$82K
- Jazz Pharmaceuticals Inc.$77K
- plus $164K from 11 others
Across 1 payment — averaging $1620.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Servier Bioinnovation | 163 | $1,570,450 |
| E.r. Squibb & Sons, L.L.C. | 1 | $639,573 |
| Novocure GmbH | 17 | $242,137 |
| Servier Pharmaceuticals LLC | 20 | $95,021 |
| Agios Pharmaceuticals, Inc. | 12 | $81,914 |
| Jazz Pharmaceuticals Inc. | 8 | $77,090 |
| Bristol Myers Squibb | 3 | $60,650 |
| GT Medical Technologies, Inc | 49 | $56,974 |
| Monteris Medical Corporation | 18 | $42,517 |
| Novartis | 2 | $1,710 |
| Seagen Inc. | 1 | $1,513 |
| Novocure Inc. | 5 | $328 |
| Foundation Medicine, Inc. | 1 | $124 |
| Lilly USA, LLC | 2 | $96 |
| BTG International Inc. | 1 | $50 |
| Blue Earth Diagnostics | 1 | $28 |
| CSL Behring | 1 | $14 |
How this compares
$2,870,188 in reported general payments places this provider in the 95th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Los Angeles
- Timothy CloughesyLos Angeles$33.1M
- Perry ShiehLos Angeles$8.2M
- Jeffrey SaverLos Angeles$2.9M
- David LiebeskindLos Angeles$2.7M
- Michele TagliatiLos Angeles$2.5M
- Jennifer HuiLos Angeles$2.4M
- Susan PerlmanLos Angeles$2.2M
- Jeffrey CummingsLos Angeles$2M
- Bryan SpannLos Angeles$1.8M
- Lilyana AmezcuaLos Angeles$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.